1.Joining WHO of Republic of Korea and the Projects in the 1950s.
Korean Journal of Medical History 2014;23(1):99-126
The Republic of Korea(ROK) and the World Health Organization(WHO) have done many projects successfully from 1949, in which the government of First Republic joined the WHO. However the relation between the ROK and the WHO have not been studied very much so far. The main purpose of this research, which could be done by the support of WHO, is connected with three questions. First research point would be "how could the ROK joined WHO in 1949 and what's the meaning of it? And the what's the difference in the process for the WHO between the ROK of 1949 and the DPRK(Democratic People's Republic of Korea) of 1973?" The first president of the ROK, Rhee Syngman, who had received his Ph. D.(about international politics) from Princeton University in 1910, was strongly interested in joining international institutes like UN, WHO. The ROK that could join WHO on 17 August 1949, with the approval of Assembly on 25 May 1949, was one of the founder members of the Western Pacific Region. By joining WHO, the ROK could get chance to increase the level of public health and its administration in 1950's. But the DPRK manage to became a member of WHO on 19 May 1973 and joined the South-East Asia Region. The joining of DPRK was influenced by the easing of the cold war after the Nixon Doctrine and the joining of the China(People's Republic of China). Second research point would be "What kind of roll did the WHO take in the First Republic?" Yet the public health administration of the First Republic that had been made in the period of US army military government was been strongly influenced by USA, the roll of WHO was also important in the 1950's. Last research point would be "What kind of the projects did the ROK and the WHO take part in during the period of he First Republic? How could evaluate the results?" The ROK and the WHO handled the projects including health services, communicable disease prevention and control, control of noncommunicable diseases, and protection of health. Specially for the efforts to prevent communicable disease, the WHO focused on leprosy, malaria, measles, smallpox, tuberculosis in 1950's. The First Republic could overcome the bad health condition after the Korea War successfully, supported by WHO.
History, 20th Century
;
*Politics
;
Public Health/*history
;
Republic of Korea
;
World Health Organization/*history
2.The development of World Federation of Acupuncture-Moxibustion Societies.
Hong-cai WANG ; Liang-yue DENG ; Bao-yan LIU
Chinese Acupuncture & Moxibustion 2014;34(10):1028-1030
From cooperation between World Federation of Acupuncture-Moxibustion Societies (WFAS) and World Health Organization, works of academics and standardization, acupuncture-moxibustion education, technique service, organization development, etc., the 27-year development of WFAS since 1987 was summarized and reviewed in details. The growth of WFAS witnesses and promotes the development of acupuncture and moxibustion in the world, so by learning the experience and lessons, WFAS could have a wider path, becoming a core organization for communicating and promoting the development of acupuncture, even the traditional medicine in the world.
Acupuncture
;
education
;
history
;
organization & administration
;
standards
;
Acupuncture Therapy
;
history
;
standards
;
Global Health
;
history
;
History, 20th Century
;
History, 21st Century
;
Humans
;
Moxibustion
;
history
;
standards
;
Societies
;
history
;
World Health Organization
3.Plague in Iran: its history and current status.
Abdolrazagh HASHEMI SHAHRAKI ; Elizabeth CARNIEL ; Ehsan MOSTAFAVI
Epidemiology and Health 2016;38(1):e2016033-
OBJECTIVES: Plague remains a public health concern worldwide, particularly in old foci. Multiple epidemics of this disease have been recorded throughout the history of Iran. Despite the long-standing history of human plague in Iran, it remains difficult to obtain an accurate overview of the history and current status of plague in Iran. METHODS: In this review, available data and reports on cases and outbreaks of human plague in the past and present in Iran and in neighboring countries were collected, and information was compiled regarding when, where, and how many cases occurred. RESULTS: This paper considers the history of plague in Persia (the predecessor of today’s Iran) and has a brief review of plague in countries in the World Health Organization Eastern Mediterranean Region, including a range of countries in the Middle East and North Africa. CONCLUSIONS: Since Iran has experienced outbreaks of plague for several centuries, neighboring countries have reported the disease in recent years, the disease can be silent for decades, and the circulation of Yersinia pestis has been reported among rodents and dogs in western Iran, more attention should be paid to disease monitoring in areas with previously reported human cases and in high-risk regions with previous epizootic and enzootic activity.
Africa, Northern
;
Animals
;
Disease Outbreaks
;
Dogs
;
History of Medicine
;
Humans
;
Iran*
;
Mediterranean Region
;
Middle East
;
Persia
;
Plague*
;
Public Health
;
Rodentia
;
World Health Organization
;
Yersinia pestis
4.Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat.
Annals of the Academy of Medicine, Singapore 2008;37(6):510-517
Fears of a potential pandemic due to A(H5N1) viruses have focussed new attention on our current vaccines, their shortcomings, and concerns regarding global vaccine supply in a pandemic. The bulk of current vaccines are inactivated split virus vaccines produced from egg-grown virus and have only modest improvements compared with those first introduced over 60 years ago. Splitting, which was introduced some years ago to reduce reactogenicity, also reduces the immunogenicity of vaccines in immunologically naïve recipients. The A(H5N1) viruses have been found poorly immunogenic and present other challenges for vaccine producers which further exacerbate an already limited global production capacity. There have been some recent improvements in vaccine production methods and improvements to immunogenicity by the development of new adjuvants, however, these still fall short of providing timely supplies of vaccine for all in the face of a pandemic. New approaches to influenza vaccines which might fulfil the demands of a pandemic situation are under evaluation, however, these remain some distance from clinical reality and face significant regulatory hurdles.
Animals
;
Birds
;
Disease Outbreaks
;
prevention & control
;
statistics & numerical data
;
Global Health
;
History, 20th Century
;
History, 21st Century
;
Humans
;
Influenza A Virus, H5N1 Subtype
;
isolation & purification
;
Influenza Vaccines
;
history
;
Influenza in Birds
;
epidemiology
;
prevention & control
;
Influenza, Human
;
epidemiology
;
prevention & control
;
World Health Organization
5.A Clinical Review of Primary Pulmonary Hypertension.
Won Dong LEE ; Dong Soo KIM ; Jae Ho LEE ; Kyoung Im CHO ; Kil Hyun CHO ; Dae Kyeong KIM ; Doo Il KIM ; Young Min LEE ; Jong Seon PARK ; Young Jo KIM ; Tae Joon CHA ; Jae Woo LEE
Korean Circulation Journal 2003;33(6):507-512
BACKGROUND AND OBJECTIVES: Primary (idiopathic) pulmonary hypertension is a rare, progressive and fatal disease. It has been defined, by the World Health Organization, as a mean pulmonary arterial pressure greater than 25 mmHg at rest, or greater than 30 mmHg during exercise, without the apparent cause of secondary pulmonary hypertension. This study was performed to better understanding the clinical presentation, natural history and prognosis of primary pulmonary hypertension. SUBJECTS AND METHODS: A total of 18 patients, who were diagnosed as primary pulmonary hypertension, at three University Hospitals, were retrospectively reviewed. All patients had undergone echocardiography and cardiac catheterization. RESULTS: With the patients there was a male: female ratio of 1:8, ranging in age between 10 and 50 years. The most common presenting symptom was dyspnea on exertion, with other symptoms comprising of fatigue in 11, chest pain in 5, syncope in 3 and hemoptysis in 2. The ECG & echocardiography reflected the presence of right-sided heart enlargement. The average right ventricular systolic pressure, from Doppler echocardiography, was 73.6+/-18.8 mmHg. The mean pulmonary artery pressure and pulmonary capillary wedge pressure were 52.9+/-18.4 and 9.2+/-3.1 mmHg, respectively. The survival times were within 30 and 21 to 60 months in 9 and the remaining patients, respectively. CONCLUSION: We conclude that primary pulmonary hypertension is common in female patients in their third to fifth decades. This study also showed a poor prognosis, as in other reports.
Arterial Pressure
;
Blood Pressure
;
Cardiac Catheterization
;
Cardiac Catheters
;
Cardiomegaly
;
Chest Pain
;
Dyspnea
;
Echocardiography
;
Echocardiography, Doppler
;
Electrocardiography
;
Fatigue
;
Female
;
Hemoptysis
;
Hospitals, University
;
Humans
;
Hypertension, Pulmonary*
;
Male
;
Natural History
;
Prognosis
;
Pulmonary Artery
;
Pulmonary Wedge Pressure
;
Retrospective Studies
;
Syncope
;
World Health Organization
6.A Clinical Review of Papillary Microcarcinoma of the Thyroid.
Bugoan CHO ; Jaeyoung CHOI ; Jeong Hoon KIM
Korean Journal of Endocrine Surgery 2006;6(2):87-93
PURPOSE: Most cases of papillary microcarcinomas of the thyroid (PMC) are not palpable and are clinically asymptomatic. The natural history of the microcarcinoma is unclear and remains debatable. There is continued discussion of whether thyroid microcarcinomas should be treated surgically and to what extent surgical removal should be extended. The main goal of this study was to analyze the clinical features and to determine the appropriate surgical treatment for well differentiated PMC in one lobe of the thyroid with favorable features in regard to consideration of radical surgery. METHODS: We studied 134 patients with the histological diagnosis of PMC from March 2003 to January 2006. The tumor was defined as 10 mm or less in the greatest diameter according to the World Health Organization guidelines. For all patients we confirmed the diagnosis by ultrasoundguided fine-needle aspiration biopsy (US-FNAB) preoperatively. There were 11 men and 123 women. The age at initial treatment ranged from 22 to 74 years (mean 46). Thyroid resection was lobectomy in 31 (23.1%) and total thyroidectomy (TT) in 103 (76.9%). CCND was performed routinely at the time of thyroidectomy. Lateral neck dissection was carried out in eight patients (5.9%) who had biopsy-proven metastatic cervical lymphadenopathy demonstrated clinically or by imaging. Patient records were reviewed retrospectively. Categorical variables were analyzed using the chi-square test or Fisher's exact test. Two-sided Student's t-test was used to compare paired data. RESULTS: The mean tumor size was 6.77 mm. PMC was associated in 36.6% (49/134) with lymph node metastasis, in 20.1% (27/134) with multifocality and in 26.9% (36/134) with capsular invasion. The mean tumor size differences influenced lymph node metastasis (LNM) (P<0.05). Capsular invasion (38.8%, 19/49) and multifocality (30.6%, 15/49) were associated with LNM (P=0.018, 0.022 respectively). The subdivision of primary tumors according to size (
Biopsy, Fine-Needle
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Humans
;
Incidence
;
Lymph Node Excision
;
Lymph Nodes
;
Lymphatic Diseases
;
Male
;
Mortality
;
Natural History
;
Neck Dissection
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
;
Thyroid Gland*
;
Thyroidectomy
;
World Health Organization